1-20 of 20
Maria Serova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C268: MET-inhibition using SU11274 and HER-inhibitions with lapatinib impair proliferation, motility and invasion in hepatocellular carcinoma (HCC) and exhibits an increased efficacy un sorafenib-tolerant model.

Annemilai Tijeras-Raballand, Eugenia Riveiro, Maria Serova, Cindy Neuzillet, Matthieu Martinet, Valérie Paradis, Mohamed Bouattour, Eric Raymond, Sandrine Faivre, Armand de Gramont
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C268.
https://doi.org/10.1158/1535-7163.TARG-13-C268
Published: 01 November 2013
View article titled, Abstract C268: MET-inhibition using SU11274 and HER-inhibitions with lapatinib impair proliferation, motility and invasion in hepatocellular carcinoma (HCC) and exhibits an increased efficacy un sorafenib-tolerant model.
Journal Articles

Abstract A194: OTX008, a small molecule that inhibits galectin-1, potentiates the in vitro effects of cytotoxic and targeted agents in several human cancer models.

Lucile Astorgues-xerri, Maria Eugenia Riveiro, Kay Noel, Esteban Cvitkovic, Mohamed Bekradda, Maria Serova, Sandrine Faivre, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A194.
https://doi.org/10.1158/1535-7163.TARG-13-A194
Published: 01 November 2013
View article titled, Abstract A194: OTX008, a small molecule that inhibits galectin-1, potentiates the in vitro effects of cytotoxic and targeted agents in several human cancer models.
Journal Articles

Abstract A188: MET inhibition by SU11274 impairs proliferation, motility, and invasion in hepatocellular and cholangiocarcinomas.

Annemilai Tijeras-Raballand, Camille Serrate, Maria Eugenia Riveiro, Maria Serova, Nathalie Guedj, Ivan Bieche, Valerie Paradis, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A188.
https://doi.org/10.1158/1535-7163.TARG-11-A188
Published: 12 November 2011
View article titled, Abstract A188: MET inhibition by SU11274 impairs proliferation, motility, and invasion in hepatocellular and cholangiocarcinomas.
Journal Articles

Abstract B175: TGF-β-RI kinase inhibitors LY2157299 and LY364947 decrease motility and invasion in hepatocarcinoma (HCC) cells developing resistance to VEGFR/PDGFR kinase inhibitors.

Maria Serova, Maria Eugenia Riveiro, Armand de Gramont, Annemilai Tijeras-Raballand, Ivan Bieche, Matthieu Martinet, Mohamed Bouattour, Karim A. Benhadji, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B175.
https://doi.org/10.1158/1535-7163.TARG-11-B175
Published: 12 November 2011
View article titled, Abstract B175: TGF-β-RI kinase inhibitors LY2157299 and LY364947 decrease motility and invasion in hepatocarcinoma (HCC) cells developing resistance to VEGFR/PDGFR kinase inhibitors.
Journal Articles

Abstract B80: Targeting CXCR4/CXCL12 axis as strategy to inhibit tumor cell invasion in RTKi-tolerant HCC models.

Maria Eugenia Riveiro, Maria Serova, Annemilai Tijeras-Raballand, Guillemette Huet, Safi Dokmak, Anne Couvelard, Sebastien Albert, Matthieu Martinet, Ivan Bieche, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B80.
https://doi.org/10.1158/1535-7163.TARG-11-B80
Published: 12 November 2011
View article titled, Abstract B80: Targeting CXCR4/CXCL12 axis as strategy to inhibit tumor cell invasion in RTKi-tolerant HCC models.
Journal Articles

Abstract C76: Inhibition of galectin-1 expression by OTX008, a novel calyx[4]arene, is associated with antiproliferative and antiangiogenic activity in human tumor xenograft models.

Lucile Astorgues-Xerri, Annemilai Tijeras-Raballand, Maria Serova, Ivan Bieche, Maria E. Riveiro, Patrice Herait, Esteban Cvitkovic, Kay Noel, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C76.
https://doi.org/10.1158/1535-7163.TARG-11-C76
Published: 12 November 2011
View article titled, Abstract C76: Inhibition of galectin-1 expression by OTX008, a novel calyx[4]arene, is associated with antiproliferative and antiangiogenic activity in human tumor xenograft models.
Journal Articles

Spectrum of Cellular Responses to Pyriplatin, a Monofunctional Cationic Antineoplastic Platinum(II) Compound, in Human Cancer Cells

Katherine S. Lovejoy, Maria Serova, Ivan Bieche, Shahin Emami, Maurizio D'Incalci, Massimo Broggini, Eugenio Erba, Christian Gespach, Esteban Cvitkovic, Sandrine Faivre, Eric Raymond, Stephen J. Lippard
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (9): 1709–1719.
https://doi.org/10.1158/1535-7163.MCT-11-0250
Published: 07 September 2011
View article titled, Spectrum of Cellular Responses to Pyriplatin, a Monofunctional Cationic Antineoplastic Platinum(II) Compound, in Human Cancer Cells
Open the PDF for Spectrum of Cellular Responses to Pyriplatin, a Monofunctional Cationic Antineoplastic Platinum(II) Compound, in Human Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Epithelial-to-Mesenchymal Transition and Oncogenic Ras Expression in Resistance to the Protein Kinase Cβ Inhibitor Enzastaurin in Colon Cancer Cells

Maria Serova, Lucile Astorgues-Xerri, Ivan Bieche, Sebastien Albert, Michel Vidaud, Karim A. Benhadji, Shahin Emami, Dominique Vidaud, Pascal Hammel, Nathalie Theou-Anton, Christian Gespach, Sandrine Faivre, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (5): 1308–1317.
https://doi.org/10.1158/1535-7163.MCT-10-0167
Published: 09 May 2010
View article titled, Epithelial-to-Mesenchymal Transition and Oncogenic Ras Expression in Resistance to the Protein Kinase Cβ Inhibitor Enzastaurin in Colon Cancer Cells
Open the PDF for Epithelial-to-Mesenchymal Transition and Oncogenic Ras Expression in Resistance to the Protein Kinase Cβ Inhibitor Enzastaurin in Colon Cancer Cells in another window
Journal Articles

Abstract C100: Evaluation of pyriplatin, a monofunctional cationic platinum(II) compound, in human cancer cells

Katherine S. Lovejoy, Maria Serova, Shahin Emami, Ivan Bieche, Christian Gespach, Esteban Cvitkovic, Sandrine Faivre, Eric Raymond, Stephen J. Lippard
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C100.
https://doi.org/10.1158/1535-7163.TARG-09-C100
Published: 10 December 2009
View article titled, Abstract C100: Evaluation of pyriplatin, a monofunctional cationic platinum(II) compound, in human cancer cells
Journal Articles

Abstract B166: Effects of PTX‐008, a non‐peptidic topomimetic targeting galectin‐1 in human epithelial cancer cells

Lucile Astorgues‐Xerri, Maria Serova, Ivan Bieche, Sabrina Vivier, Esteban Cvitkovic, Kay Noel, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B166.
https://doi.org/10.1158/1535-7163.TARG-09-B166
Published: 10 December 2009
View article titled, Abstract B166: Effects of PTX‐008, a non‐peptidic topomimetic targeting galectin‐1 in human epithelial cancer cells
Journal Articles

Abstract B141: Effects of AZD8055, a novel mTOR kinase inhibitor, in human cancer cells developing resistance to rapamycin

Maria Serova, Jacqueline Koumaravel, Ivan Bieche, Michel Vidaud, Sylvie Guichard, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B141.
https://doi.org/10.1158/1535-7163.TARG-09-B141
Published: 10 December 2009
View article titled, Abstract B141: Effects of AZD8055, a novel mTOR kinase inhibitor, in human cancer cells developing resistance to rapamycin
Journal Articles

Abstract B151: Epithelial‐to‐mesenchymal transition (EMT) in resistance to the antiproliferative effects of elisidepsin (Irvalec™), a novel marine‐derived depsipeptide, in colon cancer cells

Maria Serova, Ivan Bieche, Shahin Emami, Christian Gespach, Geert Berx, Sabrina Vivier, Michel Vidaud, Miguel Aracil, Sandrine Faivre, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B151.
https://doi.org/10.1158/1535-7163.TARG-09-B151
Published: 10 December 2009
View article titled, Abstract B151: Epithelial‐to‐mesenchymal transition (EMT) in resistance to the antiproliferative effects of elisidepsin (Irvalec™), a novel marine‐derived depsipeptide, in colon cancer cells
Journal Articles

Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells

Maria Serova, Aïda Ghoul, Karim A. Benhadji, Sandrine Faivre, Christophe Le Tourneau, Esteban Cvitkovic, Francois Lokiec, Janet Lord, Steven M. Ogbourne, Fabien Calvo, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 915–922.
https://doi.org/10.1158/1535-7163.MCT-07-2060
Published: 15 April 2008
View article titled, Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells
Open the PDF for Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells in another window
Journal Articles

AS703569, a novel aurora kinase inhibitor, enhances the antiproliferative effects of other targeted therapies in human cancer cell lines

Maria Serova, Nasredine Aissat, Aida Ghoul, Christophe Le Tourneau, Angela Romanelli, Athos Gianella-Borradori, Esteban Cvitkovic, Eric Raymond, sandrine faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C188.
Published: 01 November 2007
View article titled, AS703569, a novel aurora kinase inhibitor, enhances the antiproliferative effects of other targeted therapies in human cancer cell lines
Journal Articles

Resistance to PKCδ activators yield an increased endothelin-1-mediated invasive phenotype in human cancer cells

Aida Ghoul, Maria Serova, Ivan Bieche, Nasredine Aissat, Christophe Le Tourneau, Michel Vidaud, Francois Lokiec, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A183.
Published: 01 November 2007
View article titled, Resistance to PKCδ activators yield an increased endothelin-1-mediated invasive phenotype in human cancer cells
Journal Articles

Antiproliferative effects of sunitinib and sorafenib, two potent multitarget tyrosine kinase inhibitors, in a panel of human cancer cell lines.

Marie-Paule Sablin, Maria Serova, Nasredine Aissat, Guilhem Bousquet, Aida Ghoul, Ivan Bieche, Michel Vidaud, Chantal Dreyer, Pascal Hammel, Sandrine Faivre, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A249.
Published: 01 November 2007
View article titled, <sup><sub>Antiproliferative effects of sunitinib and sorafenib, two potent multitarget tyrosine kinase inhibitors, in a panel of human cancer cell lines.</sub></sup>
Journal Articles

Antiproliferative activity of AP5346, a novel DACH-platinum compound, alone and in combination with other cytotoxics, in human colon and ovarian cancer cells

Nasredine Aissat, Maria Serova, Aida Ghoul, David Nowotnik, Esteban Cvitkovic, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C110.
Published: 01 November 2007
View article titled, Antiproliferative activity of AP5346, a novel DACH-platinum compound, alone and in combination with other cytotoxics, in human colon and ovarian cancer cells
Journal Articles

Molecular and cellular effects of AP5346, a novel DACH-platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines

Maria Serova, Nasredine Aissat, Aida Ghoul, Keyvan Rezai, Ivan Bieche, Michel Vidaud, Sergio Szyldergemajn, David Nowotnik, Francois Lokiec, Sandrine Faivre, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C105.
Published: 01 November 2007
View article titled, Molecular and cellular effects of AP5346, a novel DACH-platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines
Journal Articles

Antiproliferative activity of AS703569, a novel aurora kinase inhibitor, given as a single agent and in combination with EGFR inhibitors in human head and neck squamous cell carcinoma (HNSCC).

Nasredine Aissat, Maria Serova, Aida Ghoul, Ivan Bieche, Michel Vidaud, Christophe Le Tourneau, Angela Romanelli, athos gianella-borradori, Esteban Cvitovic, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C194.
Published: 01 November 2007
View article titled, Antiproliferative activity of AS703569, a novel aurora kinase inhibitor, given as a single agent and in combination with EGFR inhibitors in human head and neck squamous cell carcinoma (HNSCC).
Journal Articles

Cellular and molecular mechanisms of action of AS703569, a novel aurora kinase inhibitor, in human cancer cell lines

Nasredine Aissat, Maria Serova, Aida Ghoul, Christophe Le Tourneau, Angela Romanelli, Athos Gianella-Boradorri, Esteban Cvitovic, Sandrine Faivre, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C197.
Published: 01 November 2007
View article titled, Cellular and molecular mechanisms of action of AS703569, a novel aurora kinase inhibitor, in human cancer cell lines